|
1
|
Factors affecting epirubicin pharmacokinetics and toxicity: evidence against using body-surface area for dose calculation.
|
J Clin Oncol
|
1998
|
3.81
|
|
2
|
Prognostic value of quality-of-life scores during chemotherapy for advanced breast cancer. Australian New Zealand Breast Cancer Trials Group.
|
J Clin Oncol
|
1992
|
2.67
|
|
3
|
Improving the quality of life during chemotherapy for advanced breast cancer. A comparison of intermittent and continuous treatment strategies.
|
N Engl J Med
|
1987
|
2.37
|
|
4
|
Randomised trial of SIR-Spheres plus chemotherapy vs. chemotherapy alone for treating patients with liver metastases from primary large bowel cancer.
|
Ann Oncol
|
2001
|
2.20
|
|
5
|
Competing risks analysis of patients with osteosarcoma: a comparison of four different approaches.
|
Stat Med
|
2001
|
2.04
|
|
6
|
The effect of waiting for radiotherapy for grade III/IV gliomas.
|
Radiother Oncol
|
2000
|
2.01
|
|
7
|
Effect of global system for mobile communication (gsm)-like radiofrequency fields on vascular permeability in mouse brain.
|
Pathology
|
2001
|
1.75
|
|
8
|
Driving and patients with brain tumours: a postal survey of neurosurgeons, neurologists and radiation oncologists.
|
J Clin Neurosci
|
2004
|
1.73
|
|
9
|
The misuse of mammography in the management of breast cancer revisited.
|
Med J Aust
|
1989
|
1.73
|
|
10
|
Markers of systemic inflammation predict survival in patients with advanced renal cell cancer.
|
Br J Cancer
|
2013
|
1.60
|
|
11
|
Prognosis after breast recurrence following conservative surgery and radiotherapy in patients with node-negative breast cancer.
|
Br J Surg
|
1999
|
1.45
|
|
12
|
Accelerated BEP for metastatic germ cell tumours: a multicenter phase II trial by the Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP).
|
Ann Oncol
|
2014
|
1.44
|
|
13
|
Increased plasma beta-thromboglobulin in patients with coronary artery vein graft occlusion: response to low dose aspirin.
|
J Am Coll Cardiol
|
1990
|
1.44
|
|
14
|
Radiation therapy: are we getting value for money?
|
Clin Oncol (R Coll Radiol)
|
1995
|
1.42
|
|
15
|
An Australasian assessment of the basic treatment equivalent model derived from New South Wales data.
|
Australas Radiol
|
1999
|
1.39
|
|
16
|
Randomised, non-comparative phase II study of weekly docetaxel with cisplatin and 5-fluorouracil or with capecitabine in oesophagogastric cancer: the AGITG ATTAX trial.
|
Br J Cancer
|
2010
|
1.39
|
|
17
|
Immediate postoperative aspirin improves vein graft patency early and late after coronary artery bypass graft surgery. A placebo-controlled, randomized study.
|
Circulation
|
1991
|
1.23
|
|
18
|
Lymphomas in E mu-Pim1 transgenic mice exposed to pulsed 900 MHZ electromagnetic fields.
|
Radiat Res
|
1997
|
1.23
|
|
19
|
Randomized comparison of the effects of tamoxifen, megestrol acetate, or tamoxifen plus megestrol acetate on treatment response and survival in patients with metastatic breast cancer.
|
Ann Oncol
|
1993
|
1.14
|
|
20
|
Final overall survival results of phase III GCIG CALYPSO trial of pegylated liposomal doxorubicin and carboplatin vs paclitaxel and carboplatin in platinum-sensitive ovarian cancer patients.
|
Br J Cancer
|
2012
|
1.11
|
|
21
|
Gefitinib treatment in hormone-resistant and hormone receptor-negative advanced breast cancer.
|
Ann Oncol
|
2009
|
1.04
|
|
22
|
Health-related quality of life in recurrent platinum-sensitive ovarian cancer--results from the CALYPSO trial.
|
Ann Oncol
|
2012
|
1.01
|
|
23
|
Somatostatin receptor expression, tumour response, and quality of life in patients with advanced hepatocellular carcinoma treated with long-acting octreotide.
|
Br J Cancer
|
2006
|
1.01
|
|
24
|
Does waiting time affect the outcome of larynx cancer treated by radiotherapy?
|
Radiother Oncol
|
1997
|
0.97
|
|
25
|
Efficacy of oral or intrauterine device-delivered progestin in patients with complex endometrial hyperplasia with atypia or early endometrial adenocarcinoma: a meta-analysis and systematic review of the literature.
|
Gynecol Oncol
|
2011
|
0.96
|
|
26
|
High discordance rates between sub-areolar and peri-tumoural breast lymphoscintigraphy.
|
Eur J Surg Oncol
|
2013
|
0.91
|
|
27
|
Carboplatin-paclitaxel-induced leukopenia and neuropathy predict progression-free survival in recurrent ovarian cancer.
|
Br J Cancer
|
2011
|
0.90
|
|
28
|
Self-reported health-related quality of life is an independent predictor of chemotherapy treatment benefit and toxicity in women with advanced breast cancer.
|
Br J Cancer
|
2010
|
0.89
|
|
29
|
Less pain does equal better quality of life following strontium-89 therapy for metastatic prostate cancer.
|
Br J Cancer
|
2001
|
0.89
|
|
30
|
Radiation therapy for cervix carcinoma: benefits of individualized dosimetry.
|
Clin Oncol (R Coll Radiol)
|
2002
|
0.89
|
|
31
|
Protection against recurrent acute bronchitis after oral immunization with killed Haemophilus influenzae.
|
Med J Aust
|
1990
|
0.89
|
|
32
|
Maintenance chemotherapy in limited small cell lung cancer: a randomised controlled clinical trial.
|
Br J Cancer
|
1989
|
0.88
|
|
33
|
Swallowing performance after radiation therapy for carcinoma of the esophagus.
|
Cancer
|
1988
|
0.88
|
|
34
|
Total laparoscopic versus open surgery for stage 1 endometrial cancer: the LACE randomized controlled trial.
|
Contemp Clin Trials
|
2006
|
0.87
|
|
35
|
Tongue cancer: do patients younger than 40 do worse?
|
Aust Dent J
|
2003
|
0.87
|
|
36
|
A controlled trial of a killed Haemophilus influenzae vaccine for prevention of acute exacerbations of chronic bronchitis.
|
Aust N Z J Med
|
1991
|
0.85
|
|
37
|
Oesophageal cancer: outcome of modern surgical management.
|
Aust N Z J Surg
|
1995
|
0.84
|
|
38
|
Medroxyprogesterone acetate addition or substitution for tamoxifen in advanced tamoxifen-resistant breast cancer: a phase III randomized trial. Australian-New Zealand Breast Cancer Trials Group.
|
J Clin Oncol
|
1997
|
0.83
|
|
39
|
Internal mammary lymph node metastasis in breast cancer: predictive models to assist with prognostic influence.
|
Breast
|
2011
|
0.83
|
|
40
|
Phase II trial of weekly docetaxel for patients with relapsed ovarian cancer who have previously received paclitaxel--ANZGOG 02-01.
|
Gynecol Oncol
|
2006
|
0.83
|
|
41
|
Prognostic significance of c-erbB-2 oncogene in axillary node-negative breast cancer.
|
Aust N Z J Surg
|
1996
|
0.82
|
|
42
|
WART revisited: the treatment of epithelial ovarian cancer by whole abdominal radiotherapy.
|
Australas Radiol
|
1997
|
0.82
|
|
43
|
The value of follow-up of patients with early breast cancer treated with conservative surgery and radiation therapy.
|
Breast
|
2002
|
0.81
|
|
44
|
High-resolution lymphoscintigraphy is essential for recognition of the significance of internal mammary nodes in breast cancer.
|
Ann Oncol
|
2009
|
0.81
|
|
45
|
Historical cross-trial comparisons for competing treatments in advanced breast cancer--an empirical analysis of bias.
|
Eur J Cancer
|
2009
|
0.81
|
|
46
|
Menstruation, menstrual protection and menstrual cycle problems. The knowledge, attitudes and practices of young Australian women.
|
Med J Aust
|
1985
|
0.80
|
|
47
|
Delay in the clinical diagnosis of breast cancer: estimating its effect on prognosis, with particular reference to medical litigation.
|
Breast
|
2002
|
0.80
|
|
48
|
A prognostic nomogram to predict overall survival in patients with platinum-sensitive recurrent ovarian cancer.
|
Ann Oncol
|
2012
|
0.80
|
|
49
|
Osteolymphoma (primary bone lymphoma): an Australian review of 70 cases. Australasian Radiation Oncology Lymphoma Group (AROLG).
|
Aust N Z J Med
|
1999
|
0.80
|
|
50
|
Combining components of quality of life to increase precision and evaluate trade-offs.
|
Stat Med
|
2001
|
0.80
|
|
51
|
Prognostic index to identify patients who may not benefit from whole brain radiotherapy for multiple brain metastases from lung cancer.
|
J Med Imaging Radiat Oncol
|
2010
|
0.80
|
|
52
|
The value of S-phase and DNA ploidy analysis as prognostic markers for node-negative breast cancer in the Australian setting.
|
Pathology
|
1999
|
0.79
|
|
53
|
Use of topical misoprostol to reduce radiation-induced mucositis: results of a randomized, double-blind, placebo-controlled trial.
|
Australas Radiol
|
2006
|
0.79
|
|
54
|
Outcome following radiotherapy for loco-regionally recurrent non-small cell lung cancer.
|
Australas Radiol
|
2005
|
0.79
|
|
55
|
A nomogram to predict survival time in women starting first-line chemotherapy for advanced breast cancer.
|
Breast Cancer Res Treat
|
2011
|
0.79
|
|
56
|
Internal mammary node metastasis in breast cancer: predictive models to determine status & management algorithms.
|
Eur J Surg Oncol
|
2009
|
0.79
|
|
57
|
Radiotherapy and concurrent chemotherapy for oesophageal carcinoma.
|
Australas Radiol
|
1994
|
0.78
|
|
58
|
Radiation therapists' perspective on barriers to clinical trials research.
|
J Med Imaging Radiat Oncol
|
2008
|
0.77
|
|
59
|
Prognostic nomogram to predict progression-free survival in patients with platinum-sensitive recurrent ovarian cancer.
|
Br J Cancer
|
2011
|
0.77
|
|
60
|
A test of lymphoma induction by long-term exposure of E mu-Pim1 transgenic mice to 50 Hz magnetic fields.
|
Radiat Res
|
1998
|
0.76
|
|
61
|
Quality of life studies of the Australian New Zealand Breast Cancer Trials Group: approaches to missing data.
|
Stat Med
|
1998
|
0.76
|
|
62
|
Concurrent 5-fluorouracil, mitomycin C and irradiation in locally advanced cervix cancer.
|
Radiother Oncol
|
1995
|
0.76
|
|
63
|
Changes in sodium and uric acid concentrations in plasma during the menstrual cycle.
|
Clin Chem
|
1984
|
0.76
|
|
64
|
Elderly patients after they leave hospital.
|
Med J Aust
|
1986
|
0.76
|
|
65
|
Late rectal and urinary toxicity from conformal, dose-escalated radiation therapy for prostate cancer: a prospective study of 402 patients.
|
Australas Radiol
|
2007
|
0.76
|
|
66
|
Basal cell carcinoma of the nose: an Australian and New Zealand radiation oncology patterns-of-practice study.
|
J Med Imaging Radiat Oncol
|
2008
|
0.76
|
|
67
|
Results of a 7-day aprepitant schedule for the prevention of nausea and vomiting in 5-day cisplatin-based germ cell tumor chemotherapy.
|
Support Care Cancer
|
2012
|
0.76
|
|
68
|
Effect of impact on different regions of the head of lambs.
|
J Comp Pathol
|
2001
|
0.75
|
|
69
|
Regarding Shikama et al. IJROBP 1999;44;991-6.
|
Int J Radiat Oncol Biol Phys
|
2000
|
0.75
|
|
70
|
To BTE or not BTE: that is the question.
|
Clin Oncol (R Coll Radiol)
|
2001
|
0.75
|
|
71
|
Quality of life assessment in patients treated for metastatic cutaneous squamous cell carcinoma of the head and neck.
|
J Laryngol Otol
|
2013
|
0.75
|
|
72
|
The equivalent simple treatment visit (ESTV) model does not measure radiation oncology productivity under Australian conditions.
|
Clin Oncol (R Coll Radiol)
|
1997
|
0.75
|
|
73
|
Basic Treatment Equivalent (BTE): a new measure of linear accelerator workload.
|
Clin Oncol (R Coll Radiol)
|
1997
|
0.75
|
|
74
|
In patients with metastatic cutaneous head and neck squamous cell carcinoma to cervical lymph nodes, the extent of neck dissection does not influence outcome.
|
J Laryngol Otol
|
2012
|
0.75
|
|
75
|
An assessment of the Basic Treatment Equivalent (BTE) model as measure of radiotherapy workload.
|
Clin Oncol (R Coll Radiol)
|
1997
|
0.75
|
|
76
|
Refinement of the basic treatment equivalent model to reflect radiotherapy treatment throughput using Australasian data.
|
Australas Radiol
|
1999
|
0.75
|
|
77
|
On the receiving end. VI. Which dimensions of quality-of-life scores carry prognostic information?
|
Cancer Treat Rev
|
1996
|
0.75
|
|
78
|
Paediatric medulloblastoma: patterns of care and radiotherapy quality assurance in Australia.
|
Australas Radiol
|
2007
|
0.75
|
|
79
|
The role of the gallium scan in primary extranodal lymphoma.
|
J Nucl Med
|
1998
|
0.75
|
|
80
|
Final results of Australasian Gastrointestinal Trials Group ARCTIC study: an audit of raltitrexed for patients with cardiac toxicity induced by fluoropyrimidines.
|
Ann Oncol
|
2013
|
0.75
|
|
81
|
Locally advanced (stage III and IV) head and neck cancer: Westmead Hospital experience.
|
Aust N Z J Surg
|
1991
|
0.75
|
|
82
|
Primary invasive cancer of the vagina: outcome and complications of therapy.
|
Australas Radiol
|
1999
|
0.75
|
|
83
|
Long-term survival after radical treatment for cancer of the oesophagus.
|
Med J Aust
|
1991
|
0.75
|
|
84
|
Management of oesophageal cancer at Westmead Hospital from 1979-1985.
|
Med J Aust
|
1988
|
0.75
|